Bevacizumab Biosimilar Market Overview
Posted 2026-06-22 10:07:16
0
11
The Bevacizumab Biosimilar Market was valued at $2.18 billion in 2024 and is projected to reach $5 billion by 2035, growing at a CAGR of 7.8%. Bevacizumab biosimilars offer cost-effective alternatives to the reference biologic Avastin, treating multiple cancers by inhibiting vascular endothelial growth factor (VEGF). The market encompasses various formulation types including intravenous and subcutaneous injections, with intravenous delivery dominating due to established clinical protocols.
Key indications driving demand include colorectal cancer, lung cancer, breast cancer, cervical cancer, and renal cell carcinoma. Colorectal cancer holds the largest segment share at 36.2%. North America leads regional adoption with 42.6% market share, supported by favorable FDA biosimilar policies and robust healthcare infrastructure. Major players such as Amgen, Pfizer, Sandoz, and Biocon are investing heavily in R&D to expand their biosimilar portfolios and capture market share.
FAQ
Q1: What is the current size of the bevacizumab biosimilar market? A: The market was valued at $2.18 billion in 2024.
Q2: What is the projected growth rate through 2035? A: The market is expected to grow at a CAGR of 7.8% from 2026 to 2035.
Q3: Which cancer indication dominates the market? A: Colorectal cancer holds the largest share at 36.2%.
Search
Categories
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
Read More
Complete Thermal Solutions: How Temporary Thermal Monitoring Equipment and Infrared Camera Rental Services Are Driving Inspection Excellenc
Inspection excellence in modern industry demands access to advanced thermal imaging technology...
Bevacizumab Biosimilar Market Competitive Landscape and Innovation Trends
The Bevacizumab Biosimilar Market Share landscape is becoming increasingly competitive as major...
The Expanding Role of Adjuvants in Next-Generation Immunization Strategies
The dynamics of the Vaccine Adjuvants Market are indicative of a sector on the rise, with a...
What Should Buyers Know About Maotian Straight Air Die Grinde Choices
Straight Air Die Grinde selection is an important topic for buyers who need suitable equipment...
Gelcoat Industry Outlook Shaped by Durability Requirements and Material Advancements
Market Overview
The global gelcoat market was valued at US$1.49 billion in 2024 and is projected...